Grifols GIFLF
NASDAQ GIFLF
$11.08 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

Grifols (GIFLF) Raw Materials (2010 - 2025)

Grifols' (GIFLF) quarterly Raw Materials came in at $1.1 billion in Q4 2025, up 6.71% on a YoY basis from $1.0 billion in Q4 2024, and up 6.71% quarter-over-quarter from $1.0 billion in Q4 2024.

Analysis

Grifols (GIFLF) Raw Materials (2010 - 2025) Analysis & Trends

Grifols (GIFLF) has reported Raw Materials for 12 consecutive years, with $1.1 billion the latest figure, recorded in Q4 2025.

  • For the quarter ending Q4 2025, Raw Materials rose 6.71% year-over-year to $1.1 billion; the trailing twelve-month figure through Dec 2025 stood at $1.1 billion (up 6.71% YoY), and the FY2025 full-year result was $1.1 billion, up 3.57% from the prior year.
  • Raw Materials advanced to $1.1 billion in Q4 2025 per GIFLF's latest filing, from $1.0 billion in the prior quarter.
  • Across five years, Raw Materials topped out at $1.2 billion in Q4 2023 and bottomed at $751.7 million in Q4 2021.
  • Historically, Raw Materials has averaged $1.0 billion across 5 years, with a median of $1.1 billion in 2022.
  • The sharpest annual moves came in 2022 and 2024: Raw Materials jumped 44.53% in 2022, then fell 13.12% in 2024.
  • Over 5 years, Raw Materials stood at $751.7 million in 2021, then soared by 44.53% to $1.1 billion in 2022, then grew by 8.18% to $1.2 billion in 2023, then slipped by 13.12% to $1.0 billion in 2024, then climbed by 6.71% to $1.1 billion in 2025.
  • According to Business Quant data, Raw Materials over the past three periods registered $1.1 billion, $1.0 billion, and $1.2 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 203.97 Bn 189.99 Bn 7.24 Bn
2 Gilead Sciences 178.74 Bn 175.56 Bn 6.22 Bn
3 Vertex Pharmaceuticals 130.73 Bn 122.88 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.42 Bn 72.42 Bn 3.93 Bn
5 Argenx Se 60.40 Bn 55.21 Bn 1.37 Bn
6 Moderna 57.65 Bn 52.52 Bn 52.00 Mn
7 Alnylam Pharmaceuticals 33.37 Bn 30.07 Bn 992.69 Mn
8 Biogen 32.15 Bn 30.86 Bn 1.96 Bn
9 Roivant Sciences 29.58 Bn 29.58 Bn 1.16 Mn
10 Grifols 7.54 Bn 9.09 Bn 3.33 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.09 Bn
Dec 31, 2024 1.02 Bn
Dec 31, 2023 1.18 Bn
Dec 31, 2022 1.09 Bn
Dec 31, 2021 751.66 Mn
Dec 31, 2020 709.88 Mn
Dec 31, 2019 847.97 Mn
Dec 31, 2018 738.94 Mn
Dec 31, 2017 534.99 Mn
Dec 31, 2016 457.08 Mn
Sep 30, 2011 42.44 Mn
Sep 30, 2010 17.69 Mn